We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

87 hedge funds and large institutions have $623M invested in Avadel Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

216% more call options, than puts

Call options by funds: $3.88M | Put options by funds: $1.23M

167% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 15

100% more funds holding in top 10

Funds holding in top 10: 4 → 8 (+4)

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

18% more capital invested

Capital invested by funds: $527M → $623M (+$96M)

4% more funds holding

Funds holding: 84 → 87 (+3)

Holders
87
Holders Change
+3
Holders Change %
+3.57%
% of All Funds
2.34%
Holding in Top 10
8
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+100%
% of All Funds
0.22%
New
18
Increased
40
Reduced
15
Closed
15
Calls
$3.88M
Puts
$1.23M
Net Calls
+$2.65M
Net Calls Change
+$2.57M

Top Buyers

Rank Fund Capital Flow
1
PCM
Portolan Capital Management
Massachusetts
+$16.1M
2
JHIU
Janus Henderson Investors US
Colorado
+$10.8M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$9.93M
4
Deutsche Bank
Deutsche Bank
Germany
+$9.13M
5
CPIM
Columbia Partners Investment Management
Virginia
+$7.43M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$32.2M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$20.3M
3
SCM
Sarissa Capital Management
Connecticut
-$15.7M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$10.7M
5
RSCM
Rock Springs Capital Management
Maryland
-$6.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIP
26
Chartwell Investment Partners
Pennsylvania
$4.88M +$4.13M +230,125 New
TI
27
Turner Investments
Pennsylvania
$4.14M +$655K +36,501 +23%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$3.71M +$816K +45,500 +35%
B
29
Bailard
California
$3.28M -$1.61M -90,000 -37%
CS
30
Candriam SCA
Luxembourg
$2.8M -$1.36M -76,000 -37%
SCM
31
Suffolk Capital Management
New York
$2.75M +$87.4K +4,873 +4%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$2.69M +$2.27M +126,774 New
BIM
33
Bogle Investment Management
Massachusetts
$2.58M +$2.18M +121,625 New
PCM
34
Penn Capital Management
Pennsylvania
$2.49M -$3.04M -169,593 -59%
CCI
35
Columbus Circle Investors
$2.47M -$208K -11,596 -9%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$2.21M +$579K +32,272 +45%
WSA
37
Wall Street Associates
California
$1.92M -$373K -20,800 -19%
WMSA
38
Weiss Multi-Strategy Advisers
New York
$1.8M -$803K -44,800 -35%
RSCM
39
Rock Springs Capital Management
Maryland
$1.59M -$6.9M -385,000 -84%
Janney Montgomery Scott
40
Janney Montgomery Scott
Pennsylvania
$1.38M -$115K -6,400 -9%
Allianz Asset Management
41
Allianz Asset Management
Germany
$1.22M +$643K +35,863 +166%
OPPM
42
Opus Point Partners Management
New York
$1.1M +$179K +10,000 +24%
EDRH
43
Edmond de Rothschild Holding
Switzerland
$962K +$814K +45,400 New
EDRS
44
Edmond de Rothschild (Suisse)
Switzerland
$962K +$814K +45,400 New
UBS Group
45
UBS Group
Switzerland
$930K +$175K +9,742 +29%
Alyeska Investment Group
46
Alyeska Investment Group
Illinois
$868K -$10.7M -596,477 -94%
CS
47
Credit Suisse
Switzerland
$836K +$166K +9,251 +31%
Millennium Management
48
Millennium Management
New York
$812K -$32.2M -1,793,542 -98%
EVM
49
Eaton Vance Management
Massachusetts
$735K – – –
State Street
50
State Street
Massachusetts
$668K +$7.89K +440 +1%
1
2
3 4 5

AVDL Hedge Fund Activity: Q2 2015 in Review

87 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q2 2015, worth a combined $623M — up 18% from $527M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AVDL positions and 15 closed out — a net gain of 3 holders — while 40 added to existing stakes and 15 trimmed.

The largest buyer was Portolan Capital Management, opening a new position worth an estimated $16.1M. The largest seller was Millennium Management, cutting an estimated $32.2M.

  • 87 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q2 2015, up from 84 in Q1 2015.
  • Funds reported $623M of Avadel Pharmaceuticals stock for Q2 2015, up 18% quarter-over-quarter.
  • 18 funds opened new Avadel Pharmaceuticals positions in Q2 2015 and 15 closed out, a net change of +3 holders.
  • The largest Avadel Pharmaceuticals buyer in Q2 2015 was Portolan Capital Management, an estimated $16.1M added.
  • The largest Avadel Pharmaceuticals seller in Q2 2015 was Millennium Management, an estimated $32.2M sold.

Based on aggregated 13F filings for Q2 2015.